PEPG
PEPGEN (PEPG)
NASDAQ
$1.43+$0.005 (+0.35%)
Price as of Jun 03, 2026 7:33 PM EDT
  • $103.8M
    Market Cap
  • -5.23%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
0
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-71.0M
-7.11%
-76.5M
+12.26%
-68.1M
+25.98%
-54.1M
N/A
Depreciation and Amortization Expense
1.4M
-7.18%
1.5M
+27.11%
1.2M
+140.16%
493,000
N/A
Total Operating Expenses
93.6M
-4.22%
97.7M
+15.30%
84.8M
+24.11%
68.3M
N/A
Operating Profit
-93.6M
-4.22%
-97.7M
+15.30%
-84.8M
+24.11%
-68.3M
N/A
Interest Income
4.0M
-43.76%
7.1M
+11.59%
6.4M
+129.14%
2.8M
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
4.0M
-43.76%
7.1M
+11.59%
6.4M
+129.14%
2.8M
N/A
Total Nonoperating Income and Expense
4.0M
-43.90%
7.1M
+14.94%
6.2M
+114.02%
2.9M
N/A
Income before Taxes
-89.6M
-1.09%
-90.6M
+15.33%
-78.6M
+20.12%
-65.4M
N/A
Income Taxes
49,000
+107.94%
-617,000
-945.21%
73,000
-98.03%
3.7M
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-89.7M
-0.36%
-90.0M
+14.44%
-78.6M
+13.78%
-69.1M
N/A
Net Income from Continuing Operations Applicable to Common
-89.6M
-1.09%
-90.6M
+15.33%
-78.6M
+20.12%
-65.4M
N/A
Basic EPS and Net Income
-2.12
-25.61%
-2.85
-13.64%
-3.30
-25.34%
-4.42
N/A
Diluted EPS and Net Income
-2.12
-25.61%
-2.85
-13.64%
-3.30
-25.34%
-4.42
N/A
Basic Weighted Average Shares
42.2M
+33.68%
31.6M
+32.72%
23.8M
+52.15%
15.6M
N/A
Diluted Weighted Average Shares
42.2M
+33.68%
31.6M
+32.72%
23.8M
+52.15%
15.6M
N/A
Balance Sheet
Cash and Cash Equivalents
60.5M
+22.45%
49.4M
-38.82%
80.8M
-55.56%
181.8M
N/A
Short-Term Investments
87.9M
+24.26%
70.8M
+138.82%
29.6M
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
148.5M
+23.52%
120.2M
+8.86%
110.4M
-39.25%
181.8M
N/A
Total Current Assets
151.0M
+21.98%
123.8M
+9.84%
112.7M
-39.45%
186.1M
N/A
Accumulated Depreciation
3.9M
+28.40%
3.0M
+93.77%
1.6M
+304.11%
389,000
N/A
Property and Plant and Equipment and Net
1.9M
-48.79%
3.7M
-22.00%
4.8M
+42.85%
3.3M
N/A
Total Long-Term Assets
372,000
-12.68%
426,000
-78.59%
2.0M
+35.10%
1.5M
N/A
Total Assets
173.9M
+15.26%
150.9M
+5.47%
143.1M
-34.21%
217.4M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
2.6M
-20.75%
3.2M
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
12.6M
-24.26%
16.7M
-4.76%
17.5M
-6.89%
18.8M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
13.8M
-11.24%
15.6M
-8.96%
17.1M
-9.91%
19.0M
N/A
Total Liabilities
26.5M
-17.98%
32.3M
-6.84%
34.6M
-8.41%
37.8M
N/A
Retained Earnings
-361.1M
+33.03%
-271.5M
+49.58%
-181.5M
+76.44%
-102.9M
N/A
Total Stockholders Equity
147.4M
+24.30%
118.6M
+9.41%
108.4M
-39.64%
179.6M
N/A
Total Shares Outstanding
68.9M
+111.15%
32.6M
+36.92%
23.8M
+0.46%
23.7M
N/A
Cash Flow
Cash from Operating Activities
-81.6M
-0.89%
-82.4M
+19.38%
-69.0M
+16.42%
-59.3M
N/A
Capital Expenditures
264,000
-46.88%
497,000
-80.88%
2.6M
-30.79%
3.8M
N/A
Cash from Investing Activities
-15.2M
-59.55%
-37.7M
+17.70%
-32.0M
+752.28%
-3.8M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
108.0M
+21.67%
88.7M
+47,057.14%
-189,000
-100.17%
112.2M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-55.21%
-9.83%
-61.23%
+40.36%
-43.62%
N/A
N/A
N/A
Return on Equity
-67.39%
-14.98%
-79.26%
+45.19%
-54.59%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
11.94
+61.04%
7.41
+15.33%
6.43
N/A
N/A
N/A
Cash Ratio
4.79
+61.66%
2.96
-35.75%
4.61
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow